Literature DB >> 25784074

Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.

Ratnakar Shukla1, Ujjala Ghoshal2, Tapan N Dhole1, Uday C Ghoshal3.   

Abstract

BACKGROUND: Dysbiosis may play a role in irritable bowel syndrome (IBS), hitherto an enigmatic disorder. We evaluated selected fecal microbes in IBS patients and healthy controls (HC).
METHODS: Fecal 16S rRNA copy number of selected bacteria was studied using qPCR in 47 patients with IBS (Rome III) and 30 HC.
RESULTS: Of 47 patients, 20 had constipation (IBS-C), 20 diarrhea (IBS-D), and seven unclassified IBS (IBS-U). Relative difference in 16S rRNA copy number of Bifidobacterium (P = 0.042) was lower, while those of Ruminococcus productus-Clostridium coccoides (P = 0.016), Veillonella (P = 0.008), Bacteroides thetaiotamicron (P < 0.001), Pseudomonas aeruginosa (P < 0.001), and Gram-negative bacteria (GNB, P = 0.001) were higher among IBS patients than HC. Number of Lactobacillus (P = 0.002) was lower, while that of Bacteroides thetaiotamicron (P < 0.001) and segmented filamentous bacteria (SFB, P < 0.001) was higher among IBS-D than IBS-C. Numbers of Bacteroides thetaiotamicron (P < 0.001), P. aeruginosa (P < 0.001), and GNB (P < 0.01) were higher among IBS-C and IBS-D than HC. Quantity of SFB was higher among IBS-D (P = 0.011) and lower among IBS-C (P = 0.002) than HC. Number of Veillonella species was higher among IBS-C than HC (P = 0.002). P. aeruginosa was frequently detected among IBS than HC (46/47 [97.9 %] vs. 10/30 [33.3 %], P < 0.001). Abdominal distension (n = 34/47) was associated with higher number of Bacteroides thetaiotamicron, Clostridium coccoides, P. aeruginosa, SFB, and GNB; bloating (n = 22/47) was associated with Clostridium coccoides and GNB. Microbial flora was different among IBS than HC on principal component analysis.
CONCLUSION: Fecal microbiota was different among IBS than HC, and different sub-types were associated with different microbiota. P. aeruginosa was more frequent and higher in number among IBS patients.

Entities:  

Keywords:  Dysbiosis; Functional gastrointestinal disorder; Gastrointestinal microbiota; Quantitative real-time polymerase chain reaction

Mesh:

Substances:

Year:  2015        PMID: 25784074     DOI: 10.1007/s10620-015-3607-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  50 in total

1.  Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome.

Authors:  G C Parkes; N B Rayment; B N Hudspith; L Petrovska; M C Lomer; J Brostoff; K Whelan; J D Sanderson
Journal:  Neurogastroenterol Motil       Date:  2011-11-09       Impact factor: 3.598

Review 2.  Review article: probiotics and prebiotics in irritable bowel syndrome.

Authors:  R Spiller
Journal:  Aliment Pharmacol Ther       Date:  2008-06-04       Impact factor: 8.171

3.  Gram type-specific broad-range PCR amplification for rapid detection of 62 pathogenic bacteria.

Authors:  A Klausegger; M Hell; A Berger; K Zinober; S Baier; N Jones; W Sperl; B Kofler
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

Review 4.  Role of commensal gut bacteria in inflammatory bowel diseases.

Authors:  Gunnar Loh; Michael Blaut
Journal:  Gut Microbes       Date:  2012-10-11

Review 5.  The microbiota link to irritable bowel syndrome: an emerging story.

Authors:  Ian B Jeffery; Eamonn M M Quigley; Lena Öhman; Magnus Simrén; Paul W O'Toole
Journal:  Gut Microbes       Date:  2012-08-16

6.  Interactions between Bifidobacterium and Bacteroides species in cofermentations are affected by carbon sources, including exopolysaccharides produced by bifidobacteria.

Authors:  David Rios-Covian; Silvia Arboleya; Ana M Hernandez-Barranco; Jorge R Alvarez-Buylla; Patricia Ruas-Madiedo; Miguel Gueimonde; Clara G de los Reyes-Gavilan
Journal:  Appl Environ Microbiol       Date:  2013-09-27       Impact factor: 4.792

7.  Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome.

Authors:  Erja Malinen; Lotta Krogius-Kurikka; Anna Lyra; Janne Nikkilä; Anne Jääskeläinen; Teemu Rinttilä; Terttu Vilpponen-Salmela; Atte Johannes von Wright; Airi Palva
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

8.  Enterotypes of the human gut microbiome.

Authors:  Manimozhiyan Arumugam; Jeroen Raes; Eric Pelletier; Denis Le Paslier; Takuji Yamada; Daniel R Mende; Gabriel R Fernandes; Julien Tap; Thomas Bruls; Jean-Michel Batto; Marcelo Bertalan; Natalia Borruel; Francesc Casellas; Leyden Fernandez; Laurent Gautier; Torben Hansen; Masahira Hattori; Tetsuya Hayashi; Michiel Kleerebezem; Ken Kurokawa; Marion Leclerc; Florence Levenez; Chaysavanh Manichanh; H Bjørn Nielsen; Trine Nielsen; Nicolas Pons; Julie Poulain; Junjie Qin; Thomas Sicheritz-Ponten; Sebastian Tims; David Torrents; Edgardo Ugarte; Erwin G Zoetendal; Jun Wang; Francisco Guarner; Oluf Pedersen; Willem M de Vos; Søren Brunak; Joel Doré; María Antolín; François Artiguenave; Hervé M Blottiere; Mathieu Almeida; Christian Brechot; Carlos Cara; Christian Chervaux; Antonella Cultrone; Christine Delorme; Gérard Denariaz; Rozenn Dervyn; Konrad U Foerstner; Carsten Friss; Maarten van de Guchte; Eric Guedon; Florence Haimet; Wolfgang Huber; Johan van Hylckama-Vlieg; Alexandre Jamet; Catherine Juste; Ghalia Kaci; Jan Knol; Omar Lakhdari; Severine Layec; Karine Le Roux; Emmanuelle Maguin; Alexandre Mérieux; Raquel Melo Minardi; Christine M'rini; Jean Muller; Raish Oozeer; Julian Parkhill; Pierre Renault; Maria Rescigno; Nicolas Sanchez; Shinichi Sunagawa; Antonio Torrejon; Keith Turner; Gaetana Vandemeulebrouck; Encarna Varela; Yohanan Winogradsky; Georg Zeller; Jean Weissenbach; S Dusko Ehrlich; Peer Bork
Journal:  Nature       Date:  2011-04-20       Impact factor: 49.962

9.  Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats.

Authors:  Sophie Bourdu; Michel Dapoigny; Eric Chapuy; Fabrice Artigue; Marie-Paule Vasson; Pierre Dechelotte; Gilles Bommelaer; Alain Eschalier; Denis Ardid
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

10.  Abnormal colonic fermentation in irritable bowel syndrome.

Authors:  T S King; M Elia; J O Hunter
Journal:  Lancet       Date:  1998-10-10       Impact factor: 79.321

View more
  40 in total

Review 1.  Microbiome, Immunomodulation, and the Neuronal System.

Authors:  Eric Marietta; Irina Horwath; Veena Taneja
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

2.  Comparison of gut microbiota profile in celiac disease, non-celiac gluten sensitivity and irritable bowel syndrome: A systematic review.

Authors:  Elin Lund Transeth; Hanna Fjeldheim Dale; Gülen Arslan Lied
Journal:  Turk J Gastroenterol       Date:  2020-11       Impact factor: 1.852

Review 3.  Quantitative Risk-Benefit Analysis of Probiotic Use for Irritable Bowel Syndrome and Inflammatory Bowel Disease.

Authors:  William E Bennett
Journal:  Drug Saf       Date:  2016-04       Impact factor: 5.606

4.  Comparative Effect of the I3.1 Probiotic Formula in Two Animal Models of Colitis.

Authors:  Violeta Lorén; Josep Manyé; Mari C Fuentes; Eduard Cabré; Isabel Ojanguren; Jordi Espadaler
Journal:  Probiotics Antimicrob Proteins       Date:  2017-03       Impact factor: 4.609

5.  Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.

Authors:  Nitsan Maharshak; Yehuda Ringel; David Katibian; Ashley Lundqvist; R Balfour Sartor; Ian M Carroll; Tamar Ringel-Kulka
Journal:  Dig Dis Sci       Date:  2018-05-17       Impact factor: 3.199

6.  Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study.

Authors:  Akihiro Shimozato; Makoto Sasaki; Naotaka Ogasawara; Yasushi Funaki; Masahide Ebi; Chiho Goto; Satoshi Koikeda; Takashi Joh; Kunio Kasugai
Journal:  United European Gastroenterol J       Date:  2017-01-31       Impact factor: 4.623

Review 7.  Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms.

Authors:  Annamaria Altomare; Claudia Di Rosa; Elena Imperia; Sara Emerenziani; Michele Cicala; Michele Pier Luca Guarino
Journal:  Nutrients       Date:  2021-04-29       Impact factor: 5.717

8.  Rhamnan sulphate from green algae Monostroma nitidum improves constipation with gut microbiome alteration in double-blind placebo-controlled trial.

Authors:  Yasuhito Shimada; Masahiro Terasawa; Fumiyoshi Okazaki; Hiroko Nakayama; Liqing Zang; Kaoru Nishiura; Koichi Matsuda; Norihiro Nishimura
Journal:  Sci Rep       Date:  2021-07-05       Impact factor: 4.379

Review 9.  Treating the Metabolic Syndrome by Fecal Transplantation-Current Status.

Authors:  Stephen D H Malnick; David Fisher; Marina Somin; Manuela G Neuman
Journal:  Biology (Basel)       Date:  2021-05-20

10.  Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome.

Authors:  Kaveh Naseri; Hossein Dabiri; Mohammad Rostami-Nejad; Abbas Yadegar; Hamidreza Houri; Meysam Olfatifar; Amir Sadeghi; Saeede Saadati; Carolina Ciacci; Paola Iovino; Mohammad Reza Zali
Journal:  BMC Gastroenterol       Date:  2021-07-14       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.